Docosahexaenoic acid and neurodevelopmental outcomes of term infants

Suzanne Meldrum, Karen Simmer

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    © 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.
    Original languageEnglish
    Pages (from-to)23-28
    JournalANNALS OF NUTRITION AND METABOLISM
    Volume69
    Issue number1
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Docosahexaenoic Acids
    Pregnancy
    Seafood
    Fish Oils
    Child Development
    Unsaturated Fatty Acids
    Lactation
    Observational Studies
    Pregnant Women
    Randomized Controlled Trials
    Brain

    Cite this

    @article{48f08e3cfa8f4043893bc4a52ca6c5b4,
    title = "Docosahexaenoic acid and neurodevelopmental outcomes of term infants",
    abstract = "{\circledC} 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.",
    author = "Suzanne Meldrum and Karen Simmer",
    year = "2016",
    doi = "10.1159/000448271",
    language = "English",
    volume = "69",
    pages = "23--28",
    journal = "ANNALS OF NUTRITION AND METABOLISM",
    issn = "0250-6807",
    publisher = "S Karger AG",
    number = "1",

    }

    Docosahexaenoic acid and neurodevelopmental outcomes of term infants. / Meldrum, Suzanne; Simmer, Karen.

    In: ANNALS OF NUTRITION AND METABOLISM, Vol. 69, No. 1, 2016, p. 23-28.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Docosahexaenoic acid and neurodevelopmental outcomes of term infants

    AU - Meldrum, Suzanne

    AU - Simmer, Karen

    PY - 2016

    Y1 - 2016

    N2 - © 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.

    AB - © 2016 S. Karger AG, Basel.Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, is essential for normal brain development. DHA is found predominantly in seafood, fish oil, breastmilk and supplemented formula. DHA intake in Western countries is often below recommendations. Observational studies have demonstrated an association between DHA intake in pregnancy and neurodevelopment of offspring but cannot fully adjust for confounding factors that influence child development. Randomised clinical trials of DHA supplementation during pregnancy and/or lactation, and of term infants, have not shown a consistent benefit nor harm on neurodevelopment of healthy children born at term. The evidence does not support DHA supplementation of healthy pregnant and lactating women, nor healthy infants.

    U2 - 10.1159/000448271

    DO - 10.1159/000448271

    M3 - Article

    VL - 69

    SP - 23

    EP - 28

    JO - ANNALS OF NUTRITION AND METABOLISM

    JF - ANNALS OF NUTRITION AND METABOLISM

    SN - 0250-6807

    IS - 1

    ER -